{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:49:59Z","timestamp":1779893399554,"version":"3.53.1"},"reference-count":51,"publisher":"Informa UK Limited","issue":"9","funder":[{"DOI":"10.13039\/501100020777","name":"Zhejiang Pharmaceutical Association","doi-asserted-by":"publisher","award":["2022ZYY49"],"award-info":[{"award-number":["2022ZYY49"]}],"id":[{"id":"10.13039\/501100020777","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai \u201cRising Stars of Medical Talents\u201d Youth Development Program-Clinical Pharmacist Program","award":["SHWSRS (2021) 099"],"award-info":[{"award-number":["SHWSRS (2021) 099"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2025,9,2]]},"DOI":"10.1080\/14740338.2024.2390000","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T07:01:11Z","timestamp":1756710071000},"page":"1113-1120","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Reassessment of pioglitazone and bladder cancer based on FAERS database"],"prefix":"10.1080","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8267-4985","authenticated-orcid":false,"given":"Hai-Yan","family":"Chen","sequence":"first","affiliation":[{"name":"Affiliated Dongyang Hospital of Wenzhou Medical University","place":["Dongyang, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1030-4991","authenticated-orcid":false,"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[{"name":"Fudan University","place":["Shanghai, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Jie","family":"Yang","sequence":"additional","affiliation":[{"name":"Affiliated Dongyang Hospital of Wenzhou Medical University","place":["Dongyang, P. R .China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Fudan University","place":["Shanghai, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1595-0503","authenticated-orcid":false,"given":"Ming-Ming","family":"Yan","sequence":"additional","affiliation":[{"name":"Fudan University","place":["Shanghai, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6806-6749","authenticated-orcid":false,"given":"Xiao-Yan","family":"Qiu","sequence":"additional","affiliation":[{"name":"Fudan University","place":["Shanghai, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,9,20]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2013.03.013"},{"issue":"9","key":"e_1_3_6_3_1","first-page":"748","article-title":"FDA warning and removal of rosiglitazone from VA national formulary","volume":"19","author":"Aspinall SE","year":"2013","unstructured":"Aspinall SE, Zhao X, Good CB, et al. FDA warning and removal of rosiglitazone from VA national formulary. Am J Manag Care. 2013 Sep;19(9):748\u2013758.","journal-title":"Am J Manag Care"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/10590501.2014.877645"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/1479164118825376"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1354"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70329-2"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.2174\/1574886317666220304124756"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04325.x"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1449"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2171-z"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kjms.2013.09.011"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085479"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2012.36.5.371"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-013-0106-9"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.131223"},{"issue":"3","key":"e_1_3_6_17_1","first-page":"356","article-title":"Bladder cancer in patients with type 2 diabetes treated with pioglitazone, a comparative study","volume":"30","author":"Riaz A","year":"2018","unstructured":"Riaz A, Khan K, Afreen B, et al. Bladder cancer in patients with type 2 diabetes treated with pioglitazone, a comparative study. J Ayub Med Coll Abbottabad. 2018 Jul;30(3):356\u2013359.","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.7996"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-014-3456-9"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2668-0"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.163187"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.4103\/picr.PICR_192_18"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-1068"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2538-9"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-2412"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e3645"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2014.29.2.238"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2012.11.013"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i1541"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13049"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13774"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2021.1981856"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.10.035"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.01.009"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.09.007"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.30862"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08157-y"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-019-02984-4"},{"key":"e_1_3_6_39_1","unstructured":"Therapeutic Goods Administration. Pioglitazone and risk of bladder cancer. 2011 [cited 2021 Apr 28]. Available from: https:\/\/www.tga.gov.au\/alert\/pioglitazone-and-risk-bladder-cancer"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2009.09076.x"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2009.07.020"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4154"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2015.04.006"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djs328"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.6048"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3098"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2011.10.003"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-7"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2013.04.019"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-014-0562-6"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15483"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2022.06.001"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2024.2390000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T07:01:29Z","timestamp":1756710089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2024.2390000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,2]]}},"alternative-id":["10.1080\/14740338.2024.2390000"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2024.2390000","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-01-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}